Cochrane Abstracts
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Potentiators (specific Therapies for Class III and IV Mutations) for Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439287/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis.
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439287/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis. Accessed March 17, 2025.
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439287/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis
Potentiators (specific Therapies for Class III and IV Mutations) for Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439287/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis
ID - 439287
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439287/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
